- Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024
- Medifast Named as One of The “Best Companies To Work For” by U.S. News & World Report
- Medifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications
- Medifast Announces First Quarter 2024 Financial Results
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.81 |
---|---|
High | 19.08 |
Low | 17.86 |
Bid | 18.10 |
Offer | 19.01 |
Previous close | 18.64 |
Average volume | 361.80k |
---|---|
Shares outstanding | 10.94m |
Free float | 10.66m |
P/E (TTM) | 3.14 |
Market cap | 213.17m USD |
EPS (TTM) | 6.20 USD |
Annual div (ADY) | -- |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Sep 18 2023 |
Div pay-date | Nov 07 2023 |
Data delayed at least 15 minutes, as of Jul 22 2024 21:10 BST.
More ▼